Works by Sehhoon Park

Results: 43

Characterization of genetic aberrations in a single case of metastatic thymic adenocarcinoma.

Published in:

2017

By:

Yeonghun Lee;
Sehhoon Park;
Se-Hoon Lee;
Hyunju Lee;
Lee, Yeonghun;
Park, Sehhoon;
Lee, Se-Hoon;
Lee, Hyunju

Publication type:

journal article

Intracellular Adhesion Molecule‐1 Improves Responsiveness to Immune Checkpoint Inhibitor by Activating CD8<sup>+</sup> T Cells.

Published in:

Advanced Science, 2023, v. 10, n. 17, p. 1, doi. 10.1002/advs.202204378

By:

Lee, Se‐Hoon;
Kim, Yeongmin;
Jeon, Bu‐Nam;
Kim, Gihyeon;
Sohn, Jinyoung;
Yoon, Youngmin;
Kim, Sujeong;
Kim, Yunjae;
Kim, Hyemin;
Cha, Hongui;
Lee, Na‐Eun;
Yang, Hyunsuk;
Chung, Joo‐Yeon;
Jeong, A‐Reum;
Kim, Yun Yeon;
Kim, Sang Gyun;
Seo, Yeonhee;
Park, Sehhoon;
Jung, Hyun Ae;
Sun, Jong‐Mu

Publication type:

Article

PD‐L1 expression in resected lung adenocarcinoma: prevalence and prognostic significance in relation to the IASLC grading system.

Published in:

Histopathology, 2024, v. 84, n. 6, p. 1013, doi. 10.1111/his.15146

By:

Hwang, Soohyun;
Hong, Tae Hee;
Kim, Hong Kwan;
Cho, Juhee;
Lee, Genehee;
Choi, Sangjoon;
Park, Sehhoon;
Lee, Se‐Hoon;
Lee, Yoonseo;
Jeon, Yeong Jeong;
Lee, Junghee;
Park, Seong Yong;
Cho, Jong Ho;
Choi, Yong Soo;
Kim, Jhingook;
Zo, Jae Il;
Shim, Young Mog;
Choi, Yoon‐La

Publication type:

Article

Different prognostic role of EGFR mutation according to the IASLC histological grade in patients with resected early‐stage lung adenocarcinoma.

Published in:

Histopathology, 2023, v. 83, n. 2, p. 168, doi. 10.1111/his.14894

By:

Hong, Tae H;
Hwang, Soohyun;
Choi, Yoon‐La;
Lee, Genehee;
Park, Sehhoon;
Ahn, Myung‐Ju;
Lee, Yoonseo;
Jeon, Yeong J;
Lee, Junghee;
Shin, Sumin;
Park, Seong Y;
Cho, Jong H;
Choi, Yong S;
Kim, Jhingook;
Shim, Young M;
Cho, Juhee;
Kim, Hong K

Publication type:

Article

Adjuvant Pembrolizumab in Patients with Stage IIIA/N2 Non–Small Cell Lung Cancer Completely Resected after Neoadjuvant Concurrent Chemoradiation: A Prospective, Open-Label, Single-Arm, Phase 2 Trial.

Published in:

Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1084, doi. 10.4143/crt.2024.084

By:

Shin, Junghoon;
Park, Sehhoon;
Kim, Kyung Hwan;
Shin, Eui-Cheol;
Jung, Hyun Ae;
Cho, Jong Ho;
Sun, Jong-Mu;
Lee, Se-Hoon;
Choi, Yong Soo;
Ahn, Jin Seok;
Kim, Jhingook;
Park, Keunchil;
Shim, Young Mog;
Kim, Hong Kwan;
Noh, Jae Myoung;
Ahn, Yong Chan;
Pyo, Hongryull;
Ahn, Myung-Ju

Publication type:

Article

Combination of Dabrafenib and Trametinib in Patients with Metastatic BRAF<sup>V600E</sup>-Mutated Thyroid Cancer.

Published in:

Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1270, doi. 10.4143/crt.2023.1278

By:

Jeon, Youngkyung;
Park, Sehhoon;
Lee, Se-Hoon;
Kim, Tae Hyuk;
Kim, Sun Wook;
Ahn, Myung-Ju;
Jung, Hyun Ae;
Chung, Jae Hoon

Publication type:

Article

Clinical Practice Recommendations for the Use of Next-Generation Sequencing in Patients with Solid Cancer: A Joint Report from KSMO and KSP.

Published in:

Cancer Research & Treatment, 2024, v. 56, n. 3, p. 721, doi. 10.4143/crt.2023.1043

By:

Miso Kim;
Hyo Sup Shim;
Sheehyun Kim;
In Hee Lee;
Jihun Kim;
Shinkyo Yoon;
Hyung-Don Kim;
Inkeun Park;
Jae Ho Jeong;
Changhoon Yoo;
Jaekyung Cheon;
In-Ho Kim;
Jieun Lee;
Sook Hee Hong;
Sehhoon Park;
Hyun Ae Jung;
Jin Won Kim;
Han Jo Kim;
Yongjun Cha;
Sun Min Lim

Publication type:

Article

Neoadjuvant Nivolumab Therapy for Esophageal Squamous Cell Carcinoma: A Single-Arm, Phase II Study.

Published in:

Cancer Research & Treatment, 2024, v. 56, n. 2, p. 567, doi. 10.4143/crt.2023.897

By:

Park, Sehhoon;
Lee, Yurimi;
Lee, Jiyun;
Min, Yang Won;
Kim, Hong Kwan;
Choi, Joon Young;
Jung, Hyun Ae;
Choi, Yong Soo;
Choi, Yoon-La;
Shim, Young Mog;
Sun, Jong-Mu

Publication type:

Article

First-Line Alectinib vs. Brigatinib in Advanced Non-Small Cell Lung Cancer with ALK Rearrangement: Real-World Data.

Published in:

Cancer Research & Treatment, 2024, v. 56, n. 1, p. 61, doi. 10.4143/crt.2023.461

By:

Youngkyung Jeon;
Sehhoon Park;
Hyun Ae Jung;
Jong-Mu Sun;
Se-Hoon Lee;
Jin Seok Ahn;
Myung-Ju Ahn

Publication type:

Article

Expanded Access Program Pralsetinib in Advanced Non-Small Cell Lung Cancer with Rearranged during Transfection (RET) Gene Rearrangement.

Published in:

Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1144, doi. 10.4143/crt.2023.403

By:

Youngkyung Jeon;
Hyun Ae Jung;
Sehhoon Park;
Jong-Mu Sun;
Jin Seok Ahn;
Myung-Ju Ahn;
Keunchil Park;
Se-Hoon Lee

Publication type:

Article

Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

Published in:

Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1104, doi. 10.4143/crt.2023.502

By:

Hana Kim;
Sehhoon Park;
Hyun Ae Jung;
Se-Hoon Lee;
Keunchil Park;
Yong Chan Ahn;
Dongryul Oh;
Myung-Ju Ahn

Publication type:

Article

EGFR Mutation-Positive Unresectable Stage III Non-Squamous Lung Cancer Is Associated with a High Incidence of Brain Metastasis.

Published in:

Cancer Research & Treatment, 2023, v. 55, n. 2, p. 498, doi. 10.4143/crt.2022.388

By:

Hongsik Kim;
Sehhoon Park;
Hyun Ae Jung;
Jong-Mu Sun;
Se-Hoon Lee;
Jin Seok Ahn;
Myung-Ju Ahn

Publication type:

Article

The Role of Brain Radiotherapy before First-Line Afatinib Therapy, Compared to Gefitinib or Erlotinib, in Patients with EGFR-Mutant Non-Small Cell Lung Cancer.

Published in:

Cancer Research & Treatment, 2023, v. 55, n. 2, p. 479, doi. 10.4143/crt.2022.1344

By:

Hyun Ae Jung;
Sehhoon Park;
Se-Hoon Lee;
Jin Seok Ahn;
Myung-Ju Ahn;
Jong-Mu Sun

Publication type:

Article

Cancer-Specific Sequences in the Diagnosis and Treatment of NUT Carcinoma.

Published in:

Cancer Research & Treatment, 2023, v. 55, n. 2, p. 452, doi. 10.4143/crt.2022.910

By:

Mi-Sook Lee;
Sungbin An;
Ji-Young Song;
Minjung Sung;
Kyungsoo Jung;
Eun Sol Chang;
Juyoung Choi;
Doo-Yi Oh;
Yoon Kyung Jeon;
Hobin Yang;
Lakshmi, Chaithanya;
Sehhoon Park;
Joungho Han;
Se-Hoon Lee;
Yoon-La Choi

Publication type:

Article

Osimertinib Combined with Systemic Chemotherapy for EGFR Mutant, T790M-Negative, Non–Small Cell Lung Cancer Patients Who Develop Leptomeningeal Metastases with Extracranial Progression to Prior EGFR TKI.

Published in:

Cancer Research & Treatment, 2023, v. 55, n. 1, p. 344, doi. 10.4143/crt.2021.1603

By:

Hye Ryeon Kim;
Hyunji Jo;
Hongsik Kim;
Joohyun Hong;
Sehhoon Park;
Hyun Ae Jung;
Se-Hoon Lee;
Jin-Seok Ahn;
Myung-Ju Ahn

Publication type:

Article

A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer.

Published in:

Cancer Research & Treatment, 2022, v. 54, n. 3, p. 719, doi. 10.4143/crt.2021.1019

By:

Hye Ryeon Kim;
Su Jin Lee;
Sehhoon Park;
Hyun Ae Jung;
Se-Hoon Lee;
Han-Sin Jeong;
Man Ki Chung;
Myung-Ju Ahn

Publication type:

Article

Long-term Survival in Non-Small Cell Lung Cancer Patients with Metachronous Brain-Only Oligorecurrence Who Underwent Definitive Treatment.

Published in:

Cancer Research & Treatment, 2022, v. 54, n. 1, p. 150, doi. 10.4143/crt.2021.306

By:

Hongsik Kim;
Sehhoon Park;
Hyun Ae Jung;
Jong-Mu Sun;
Se-Hoon Lee;
Jin Seok Ahn;
Keunchil Park;
Myung-Ju Ahn

Publication type:

Article

EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation.

Published in:

Cancer Research & Treatment, 2020, v. 52, n. 4, p. 1288, doi. 10.4143/crt.2020.278

By:

Sehhoon Park;
Bo Mi Ku;
Hyun Ae Jung;
Jong-Mu Sun;
Jin Seok Ahn;
Se-Hoon Lee;
Keunchil Park;
Myung-Ju Ahn

Publication type:

Article

Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR Mutations.

Published in:

Cancer Research & Treatment, 2015, v. 47, n. 4, p. 630, doi. 10.4143/crt.2014.244

By:

Sehhoon Park;
Bhumsuk Keam;
Se Hyun Kim;
Ki Hwan Kim;
Yu Jung Kim;
Jin-Soo Kim;
Tae Min Kim;
Se-Hoon Lee;
Dong-Wan Kim;
Jong Seok Lee;
Dae Seog Heo

Publication type:

Article

Real-World Outcomes of Immunotherapy in Second- or Later-Line Non-Small Cell Lung Cancer with Actionable Genetic Alterations.

Published in:

Cancers, 2023, v. 15, n. 22, p. 5450, doi. 10.3390/cancers15225450

By:

Jun, Soojin;
Park, Sehhoon;
Sun, Jong-Mu;
Lee, Se-Hoon;
Ahn, Jin Seok;
Ahn, Myung-Ju;
Cho, Juhee;
Jung, Hyun Ae

Publication type:

Article

MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer.

Published in:

Pathology & Oncology Research, 2022, p. 01, doi. 10.3389/pore.2022.1610697

By:

Jihoon Ko;
Jaeyun Jung;
Seung Tae Kim;
Jung Yong Hong;
Sehhoon Park;
Joon Oh Park;
Young Suk Park;
Ho Yeong Lim;
Soomin Ahn;
Kyoung-Mee Kim;
Won Ki Kang;
Jeeyun Lee

Publication type:

Article

Efficacy of the PRO-CTCAE mobile application for improving patient participation in symptom management during cancer treatment: a randomized controlled trial.

Published in:

Supportive Care in Cancer, 2023, v. 31, n. 6, p. 1, doi. 10.1007/s00520-023-07779-3

By:

Lee, Mangyeong;
Kang, Danbee;
Kang, Eunjee;
Kim, Sooyeon;
Kim, Youngha;
Ahn, Jin Seok;
Park, Sehhoon;
Lee, Yoo-Young;
Oh, Dongryul;
Noh, Jae Myung;
Cho, Juhee

Publication type:

Article

Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.

Published in:

Cancer (0008543X), 2022, v. 128, n. 11, p. 2148, doi. 10.1002/cncr.34176

By:

Park, Sehhoon;
Oh, Dongryul;
Choi, Yoon‐La;
Chi, Sang Ah;
Kim, Kyunga;
Ahn, Myung‐Ju;
Sun, Jong‐Mu

Publication type:

Article

High concordance of actionable genomic alterations identified between circulating tumor DNA–based and tissue‐based next‐generation sequencing testing in advanced non–small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program

Published in:

Cancer (0008543X), 2021, v. 127, n. 16, p. 3019, doi. 10.1002/cncr.33571

By:

Park, Sehhoon;
Olsen, Steve;
Ku, Bo Mi;
Lee, Min‐Sang;
Jung, Hyun‐Ae;
Sun, Jong‐Mu;
Lee, Se‐Hoon;
Ahn, Jin Seok;
Park, Keunchil;
Choi, Yoon‐La;
Ahn, Myung‐Ju

Publication type:

Article

Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapy.

Published in:

2020

By:

Park, Sehhoon;
Shim, Joonho;
Mortimer, Peter G. S.;
Smith, Simon A.;
Godin, Robert E.;
Hollingsworth, Simon J.;
Kim, Hee‐Jung;
Jung, Hyun Ae;
Sun, Jong‐Mu;
Park, Woong‐Yang;
Ahn, Jin Seok;
Ahn, Myung‐Ju;
Lee, Se‐Hoon;
Park, Keunchil;
Kim, Hee-Jung;
Sun, Jong-Mu;
Park, Woong-Yang;
Ahn, Myung-Ju;
Lee, Se-Hoon

Publication type:

journal article

Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB-4 liver fibrosis index.

Published in:

2015

By:

Suh, Beomseok;
Yun, Jae Moon;
Park, Sehhoon;
Shin, Dong Wook;
Lee, Tae Hoon;
Yang, Hyung‐Kook;
Ahn, Eunmi;
Lee, Hyejin;
Park, Jin Ho;
Cho, BeLong

Publication type:

journal article

Prognostic value of p21-activated kinase 4 in resected pancreatic cancer.

Published in:

APMIS, 2017, v. 125, n. 8, p. 699, doi. 10.1111/apm.12705

By:

Park, Sehhoon;
Kim, Jin Won;
Kim, Haeryoung;
Kim, Ji‐Won;
Kim, Yu Jung;
Lee, Keun‐Wook;
Kim, Jee Hyun;
Kim, Jai Hwan;
Hwang, Jin‐Hyeok;
Choi, Young Rok;
Cho, Jai Young;
Yoon, Yoo‐Seok;
Han, Ho‐Seong

Publication type:

Article

Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor.

Published in:

PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0189766

By:

Park, Sehhoon;
Ha, Seunggyun;
Lee, Se-Hoon;
Paeng, Jin Chul;
Keam, Bhumsuk;
Kim, Tae Min;
Kim, Dong-Wan;
Heo, Dae Seog

Publication type:

Article

Diagnostic accuracy of MR imaging of patients with leptomeningeal seeding from lung adenocarcinoma based on 2017 RANO proposal: added value of contrast-enhanced 2D axial T2 FLAIR.

Published in:

Journal of Neuro-Oncology, 2020, v. 149, n. 2, p. 367, doi. 10.1007/s11060-020-03617-2

By:

Seong, Minjung;
Park, Sehhoon;
Kim, Sung Tae;
Park, Sung Goo;
Kim, Yi Kyung;
Kim, Hyung-Jin;
Ahn, Myung-Ju

Publication type:

Article

Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: Are They Different from Those with Common EGFR Mutations?

Published in:

Biology (2079-7737), 2020, v. 9, n. 10, p. 326, doi. 10.3390/biology9100326

By:

Jung, Hyun Ae;
Park, Sehhoon;
Sun, Jong-Mu;
Lee, Se-Hoon;
Ahn, Jin Seok;
Ahn, Myung-Ju;
Park, Keunchil

Publication type:

Article

Clinical utility of circulating tumor DNA profiling in detecting targetable fusions in non-small cell lung cancer.

Published in:

Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1463341

By:

Kim, Young-gon;
Lee, Boram;
Ha, Changhee;
Lee, Cheonghwa;
Jung, Hyun Ae;
Sun, Jong-Mu;
Lee, Se-Hoon;
Ahn, Myung-Ju;
Choi, Yoon-La;
Park, Sehhoon;
Kim, Jong-Won

Publication type:

Article

Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma.

Published in:

PLoS ONE, 2022, v. 17, n. 10, p. 1, doi. 10.1371/journal.pone.0274830

By:

Hur, Joon Young;
Ku, Bo Mi;
Park, Sehhoon;
Jung, Hyun Ae;
Lee, Se-Hoon;
Ahn, Myung-Ju

Publication type:

Article

Trends in Survival Rates of Non–Small Cell Lung Cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020.

Published in:

JAMA Network Open, 2023, v. 6, n. 3, p. e232002, doi. 10.1001/jamanetworkopen.2023.2002

By:

Chi, Sang Ah;
Yu, Hyeyeon;
Choi, Yoon-La;
Park, Sehhoon;
Sun, Jong-Mu;
Lee, Se-Hoon;
Ahn, Jin Seok;
Ahn, Myung-Ju;
Choi, Dae-Ho;
Kim, Kyunga;
Jung, Hyun Ae;
Park, Keunchil

Publication type:

Article

Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer.

Published in:

eLife, 2024, p. 1, doi. 10.7554/eLife.98366

By:

Nayoung Kim;
Sehhoon Park;
Areum Jo;
Hye Hyeon Eum;
Hong Kwan Kim;
Kyungjong Lee;
Jong Ho Cho;
Bo Mi Ku;
Hyun Ae Jung;
Jong-Mu Sun;
Se-Hoon Lee;
Jin Seok Ahn;
Jung-Il Lee;
Jung Won Choi;
Dasom Jeong;
Minsu Na;
Huiram Kang;
Jeong Yeon Kim;
Jung Kyoon Choi;
Hae-Ock Lee

Publication type:

Article

Transcriptional upregulation of CXCL13 is correlated with a favorable response to immune checkpoint inhibitors in lung adenocarcinoma.

Published in:

Cancer Medicine, 2023, v. 12, n. 6, p. 7639, doi. 10.1002/cam4.5460

By:

Park, Sehhoon;
Cha, Hongui;
Kim, Hong Sook;
Lee, Boram;
Kim, Soyeon;
Kim, Tae Min;
Jung, Hyu Ae;
Sun, Jong‐Mu;
Ahn, Jin Seok;
Ahn, Myung‐Ju;
Park, Keunchil;
Park, Woong‐Yang;
Lee, Se‐Hoon

Publication type:

Article

Longitudinal monitoring by next‐generation sequencing of plasma cell‐free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors.

Published in:

Cancer Medicine, 2022, v. 11, n. 15, p. 2944, doi. 10.1002/cam4.4663

By:

Kwon, Minsuk;
Ku, Bo mi;
Olsen, Steve;
Park, Sehhoon;
Lefterova, Martina;
Odegaard, Justin;
Jung, Hyun‐Ae;
Sun, Jong‐Mu;
Lee, Se‐Hoon;
Ahn, Jin Seok;
Park, Keunchil;
Ahn, Myung‐Ju

Publication type:

Article

Pulmonary function and toxicities of proton versus photon for limited-stage small cell lung cancer.

Published in:

Radiation Oncology Journal, 2023, v. 41, n. 4, p. 274, doi. 10.3857/roj.2023.00773

By:

Sang Hoon Seo;
Hongryull Pyo;
Yong Chan Ahn;
Dongryul Oh;
Kyungmi Yang;
Nalee Kim;
Jong-Mu Sun;
Sehhoon Park;
Hyun Ae Jung;
Se-Hoon Lee;
Jin Seok Ahn;
Myung-Ju Ahn;
Jae Myoung Noh

Publication type:

Article

Prognostic significance of body mass index in small‐cell lung cancer: Exploring the relationship with skeletal muscle status.

Published in:

Journal of Cachexia, Sarcopenia & Muscle, 2023, v. 14, n. 6, p. 2939, doi. 10.1002/jcsm.13345

By:

Kwon, Yong Jae;
Yoon, Young Cheol;
Kim, Hyun Su;
Cha, Min Jae;
Park, Sehhoon;
Lee, Ji Hyun

Publication type:

Article

Evaluating entrectinib as a treatment option for non-small cell lung cancer.

Published in:

Expert Opinion on Pharmacotherapy, 2020, v. 21, n. 16, p. 1935, doi. 10.1080/14656566.2020.1798932

By:

Lee, Jiyun;
Park, Sehhoon;
Jung, Hyun Ae;
Sun, Jong-Mu;
Lee, Se-Hoon;
Ahn, Jin Seok;
Park, Keunchil;
Ahn, Myung-Ju

Publication type:

Article

Updates on the treatment of epidermal growth factor receptor‐mutant non–small cell lung cancer.

Published in:

Cancer (0008543X), 2025, v. 131, p. 1, doi. 10.1002/cncr.35778

By:

Kim, Jinyong;
Park, Sehhoon;
Ku, Bo Mi;
Ahn, Myung‐Ju

Publication type:

Article

Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune‐related hepatitis in non–small cell lung cancer patients with chronic hepatitis B.

Published in:

Cancer (0008543X), 2024, v. 130, n. 9, p. 1693, doi. 10.1002/cncr.35175

By:

Hong, Joohyun;
Lee, Jiyun;
Park, Sehhoon;
Jung, Hyun‐Ae;
Sun, Jong‐Mu;
Lee, Se‐Hoon;
Ahn, Jin Seok;
Sinn, Dong Hyun;
Ahn, Myung‐Ju

Publication type:

Article

Biomarker‐driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer.

Published in:

Cancer (0008543X), 2024, v. 130, n. 4, p. 541, doi. 10.1002/cncr.35059

By:

Park, Sehhoon;
Kim, Yu Jung;
Min, Young Joo;
Mortimer, Peter G. S.;
Kim, Hee‐Jung;
Smith, Simon A.;
Dean, Emma;
Jung, Hyun Ae;
Sun, Jong‐Mu;
Park, Woong‐Yang;
Ahn, Jin Seok;
Ahn, Myung‐Ju;
Lee, Se‐Hoon;
Park, Keunchil

Publication type:

Article

A phase 2 multicenter study of docetaxel‐PM and trastuzumab‐pkrb combination therapy in recurrent or metastatic salivary gland carcinomas.

Published in:

Cancer (0008543X), 2023, v. 129, n. 19, p. 2966, doi. 10.1002/cncr.34892

By:

Lee, Jiyun;
Park, Sehhoon;
Jung, Hyun Ae;
Lee, Se‐Hoon;
Seo, Seyoung;
Kim, Sung‐Bae;
Kim, Ji‐Won;
Lee, Keun‐Wook;
Kang, Eun Joo;
Kim, Ju Won;
Choi, Yoon Ji;
Shim, Byoung‐Yong;
An, Ho‐Jung;
Park, Lee Chun;
Shin, Seong Hoon;
Kim, Jae‐Joon;
Oh, So Yeon;
Kim, Min Kyoung;
Ahn, Myung‐Ju

Publication type:

Article